05/23/2022 | BioRegio STERN Management GmbH | Press

Nose swabs are a thing of the past

(Stuttgart/Reutlingen) – Contexo GmbH and Mediagnost Gesellschaft für Forschung und Herstellung von Diagnostika GmbH from the STERN BioRegion are working with University Hospital Tübingen’s Institute for Medical Virology and Epidemiology of Viral Diseases to jointly develop a rapid breath test for reliably detecting bacterial and viral pathogens in the respiratory tract, especially in the case of SARS-CoV-2 infections. The ASARSI research project is receiving over 450,000 euros of funding as part of the Central Innovation Programme for SMEs (ZIM) cooperation network run by the German Federal Ministry for Economic Affairs and Climate Action (BMWK)

About Contexo

Contexo GmbH is an international machine builder operating in the medtech and biotech sectors that designs and produces single-use products for global brands and companies. Contexo specialises in approval procedures for production, assembly and test processes, including the necessary technical system documentation and enhanced GMP-compliant approval documents.

About Mediagnost

The key skills of Mediagnost Gesellschaft für Forschung und Herstellung von Diagnostika GmbH include developing serological test methods in the indication areas of infectiology and endocrinology by turning an experimental laboratory test into a marketable test kit that meets the regulatory requirements for in vitro diagnostics. Further core competences are the large-scale production of viral and bacterial antigens, and the extraction and manufacture of monoclonal antibodies that are used as raw materials in the diagnostics industry.

About the Institute for Medical Virology and Epidemiology

The Institute for Medical Virology and Epidemiology of Viral Diseases, including its Research Section Molecular Virology, is an independent division within the Department of Diagnostic Laboratory Medicine at University Hospital Tübingen. It represents the subject of virology in basic and clinical research, in teaching for students of human and dental medicine, molecular medicine, midwifery and nursing science, biochemistry, biology and bioinformatics, and also in patient care in the form of comprehensive diagnostics of human pathogenic viruses, specialist counselling for doctors and the training of medical specialists and specialist virologists.

About smart analytics

The Central Innovation Programme for SMEs (ZIM) run by the German Federal Ministry for Economic Affairs and Climate Action (BMWK) is funding an international cooperation network – smart analytics – for the development of intelligent and innovative analytical methods. BioRegio STERN Management GmbH is coordinating the international smart analytics ZIM network in Germany. The project is being funded by the BMWK and currently includes 31 partners from Europe. Other companies are welcome to become project partners. This will give them access to targeted support so that they can submit equally promising research and development applications to ZIM as necessary.

SmartAnalytics Zweierband neu 2022_EN

Verena Grimm, Dr. rer. nat.

Project Management
+49-173 371 144 9
Project Management
Verena Grimm, Dr. rer. nat.

"By participating at the trinational study course of the École supérieure de Biotechnologie de Strasbourg, I was able to gain first international study experience. After graduating with a diploma thesis in the area of Virology and Gene Therapy at the University of Michigan, I developed a DNA microarray for rapid antibiotic resistance detection during my doctorate at the Institute of Technical Biochemistry in Stuttgart. The following ten years I worked in the product and marketing management in the field of diagnostics at Greiner Bio-One GmbH, which produces multiplex analytical methods for use in food safety, human diagnostics and product safety in the pharmaceutical industry. Starting January 2017 at the BioRegio STERN Management GmbH, I will use my international experience in the development, application and marketing of biotechnological methods to network, attend and support companies in the medtech and biotech industry in the region. As project manager I support the regional companies’ prospects for automated applications and the development of new products."



Interested companies can contact Dr. Verena Grimm

BioRegio STERN Management GmbH